Report: Federal Marijuana Rescheduling Put on Hold, Details Unclear
A Monday report says the pending Schedule III process has been paused, but the available headline names no decision-maker, no document and no reason.

Close-up of a modern building with distinctive circular windows in Washington DC.
What the report actually says
The only confirmed fact is a headline: regulatoryoversight.com published "Pending Marijuana Rescheduling Put on Hold" on Oct. 5, 2026. The syndicated listing carries no text, no named official and no citation to a filing.
That's thin. CannIntel hasn't reviewed the underlying article, a Federal Register notice, a court order or a DEA statement confirming a pause. Until one of those surfaces, "on hold" is a characterization, not a documented event.
The distinction matters. A hold can mean a court stay, an agency decision, an interagency review delay or a missed deadline. Each carries a different clock.
What we can't yet verify
Five basic questions remain unanswered, and each one can be answered by a primary document. A pause with no paper trail is rumor with a URL.
- Which body imposed the hold: DEA, the Department of Justice, a court or the White House?
- Is it a formal stay, with a docket entry, or an informal slowdown?
- Does it cover the whole Schedule III rulemaking or one step, such as the hearing?
- Is there an end date or a trigger for lifting it?
- Was the pause disclosed in the Federal Register?
We'll update this story when any of those is documented.
How the process reached this point
The rescheduling track has already been stalled once, which makes a second pause plausible but not proven. Here's the public record, in order.
In August 2023, the Department of Health and Human Services recommended moving marijuana to Schedule III. On May 21, 2024, DEA published a notice of proposed rulemaking in the Federal Register proposing that change. A formal administrative hearing before an ALJ was set for January 2025 and was stayed before it began.
President Donald Trump signed an executive order in December 2025 directing the attorney general to expedite rescheduling. Whatever happened after that, the order didn't end the rulemaking; a final rule still has to be published before the schedule changes.
Nothing in today's signal tells us where in that sequence the reported hold falls.
What a hold costs operators
Every month without a final rule keeps Internal Revenue Code Section 280E in force for plant-touching businesses. Schedule III would take marijuana outside the statute's reach for state-legal operators, which is why the proposal draws more attention from finance chiefs than from clinicians.
Operators in California, Colorado and other mature markets have budgeted around that relief for two years, and some have carried tax reserves they'd rather release while others have delayed expansion.
A hold doesn't change what's owed. It changes when anyone can plan around a different number.
Rescheduling to Schedule III also wouldn't create a federal retail market. State-licensed sales would remain outside the Controlled Substances Act's registration scheme, and banking questions wouldn't vanish. A pause, in other words, delays one fix and leaves the larger legal gap untouched.
What to watch next
The answer will come from documents, not headlines. The most direct check is the DEA rulemaking docket and the Federal Register, where any formal stay, withdrawal or schedule change must appear. For full background on the timeline, see the CannIntel topic hub on DEA marijuana rescheduling.
Skeptics will say "on hold" headlines tend to outrun the paperwork. That's not a prediction, just a reason to wait for the order itself.
Next signal: a docket entry, court order or DEA statement dated on or after Oct. 5, 2026, naming who paused the rule and under what authority. Until then, treat the hold as reported, not established.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Frequently asked questions
Has marijuana rescheduling been put on hold?
regulatoryoversight.com reported on Oct. 5, 2026 that it has. CannIntel hasn't confirmed this against a Federal Register notice, court order or DEA statement, and the available headline doesn't say who imposed the pause or why.
What would Schedule III mean for cannabis businesses?
Moving marijuana to Schedule III would end the application of Internal Revenue Code Section 280E to state-legal operators, easing their federal tax burden. It wouldn't by itself legalize interstate commerce or create a federal retail market.
When did DEA propose rescheduling marijuana?
DEA published a notice of proposed rulemaking in the Federal Register on May 21, 2024, proposing Schedule III. That followed an August 2023 HHS recommendation to make the same move.
Where can readers confirm a rescheduling delay?
Check the DEA rulemaking docket and the Federal Register for any formal stay, withdrawal or final rule. Court dockets would show a judicial stay. Absent a filing, a reported hold remains unconfirmed.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

New York weighs disciplinary action against Claverack dispensary
The Daily Gazette reported Monday that state regulators are considering discipline for a Columbia County dispensary. The violations, penalty and licensee are not yet public.

Federal hemp rewrite sets different fates for delta-8 and CBD
The hemp redefinition taking effect Nov. 12, 2026 excludes lab-converted cannabinoids like delta-8 THC while capping total THC in CBD products at 0.4 mg per container.

Massachusetts Governor Urges 'No' Vote on Marijuana Sales Ban
Gov. Maura Healey came out against a ballot measure that would end legal marijuana sales, putting the state's top executive in the repeal fight five weeks before Election Day.
More from the newsroom

State orders Trulieve to fix wastewater runoff, report says
The Tallahassee Democrat reported a state order on Trulieve's wastewater runoff, but the agency, site and penalty remain unconfirmed, so investors should watch the next SEC filing.

CBT Flags Sulfur Deficiency as a Hidden Cannabis Crop Drag
Cannabis Business Times put sulfur back on the cultivation agenda, tying the overlooked nutrient to plant growth, terpene production and disease management.

Supreme Court weighs cannabis company's dispute with health department
Missouri Lawyers Media reported Oct. 5 that the Supreme Court heard competing arguments from a cannabis company and a health department; parties and legal question remain unconfirmed.